企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年3月
NEXTBIOMEDICAL Co., Ltd. is an innovative bio-solutions company that develops therapeutic materials based on polymer and drug delivery system technology; since its establishment in 2014, it has developed products reflecting the needs of clinical settings, such as endoscopic hemostatic materials and vascular embolization microspheres, and has had its technological and innovative capabilities recognized through domestic approvals and new medical technology designations as well as U.S. FDA and European CE certifications. Centered on CEO Lee Don-haeng, who has more than 30 years of clinical research and development experience, the company has research personnel capable of handling the entire process from development to commercialization, including R&D and translational research, clinical development, licensing, commercialization, and technology transfer, and it also has specialized personnel such as design history file and licensing experts and nonclinical testing staff capable of conducting its own efficacy evaluations to quickly commercialize its technologies.
代表理事
Lee Donhaeng
成立日期
2014年8月1日
法人类型
韩国创业板
行业分类
Manufacture of other medical and surgical equipment and orthopedic appliances n.e.c.
法人注册号
12011-0720228
营业执照号
131-86-63415
电话号码
032-454-4800
传真号码
032-454-4811
公司地址
6 Venture-ro 100beon-gil, Yeonsu-gu, Incheon
产品与服务
评论